This is a $468,104.64 firm-fixed-price contract awarded by the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a small disadvantaged business based in San Francisco, California. The contract is for research and development related to the clinical validation of an at-home, deep-learning based sepsis monitoring system. This contract was awarded under ASPR's Biomedical Advanced Research and Development...
This is a $9,050,674.00 definitive cost-sharing contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Cytovale Inc., a self-certified small disadvantaged business. The contract is for advancing Cytovale's biophysical early sepsis diagnostic towards U.S. Food and Drug Administration (FDA) 510(k) clearance. This contract was awarded under a Broad Agency Announcement (BAA) from the Biomedical Advanced Research...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $27,992,718.00 definitive contract to Inflammatix, Inc., a self-certified small disadvantaged business organization, for the development of "a full stack of host-response solutions to infectious disease testing to address outpatient and inpatient testing for acute infections and sepsis both during and outside of influenza season." This contract, which has a...
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Inflammatix, Inc., a small disadvantaged business. The $749,999 firm fixed-price contract supports research and development for the Triverity cartridge, a diagnostic tool focused on infection severity and sepsis detection, under Area of Interest #2 of ASPR's Easy Broad Agency Announcement. The...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Inflammatix, Inc., a self-certified small disadvantaged business. The contract is for the development of the HOSTDX-Sepsis diagnostic test, a rapid point-of-care test that analyzes the host immune response to detect and classify sepsis. The contract has a firm fixed price of $510,000.00 and a completion date of November 30, 2021....
This federal contract award, valued at $749,549.00, was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Immunexpress Inc., a for-profit foreign-owned company. The contract is for the "ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS" and is a definitive, firm-fixed-price contract with a period of performance ending on June 10, 2023. The contract award originated from a Broad...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
This is a $254,662.00 firm fixed-price definitive contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to End Sepsis, Inc., a non-profit organization, to support the Rory Staunton Maternal Sepsis Campaign. The contract was issued under a Broad Agency Announcement solicitation that sought innovations to protect Americans from natural and intentional health security threats, with a specific focus on early notification,...
<p>This is a $12,606,489.57 Firm Fixed Price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to AD Astra Diagnostics, Inc. for the research and development of a CLIA-waived ubiquitous early sepsis detection and severity assessment system for use in ambulance, pre-hospital, and post-discharge settings. The contract has an ultimate completion date of December 15, 2027 and does not have a set-aside designation.</p>
This is a $2,483,472 definitive, firm fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS) to Rizlab Health Inc., a for-profit corporate entity that develops innovative medical diagnostic technologies. The contract is for research and development to manufacture and obtain regulatory approval for the Cytotracker BV, a point-of-care platform that can rapidly distinguish between acute...